Skip to main content

Mudar localização

Você está atualmente no website Brazil (Português)

Meu país não está na lista

Global

  • Bracco.com (English)

Ásia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Américas

  • Brazil (Português)
  • Canada (English)
  • Mexico (English)
  • Canada (Français)
  • USA (English)

Europa

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Carreira
  • Contactar nos
    • Brazil (Português)
  • Página inicial
  • we are bracco
    Nós somos Bracco

    Bem-vindo(a) ao mundo dos meios de contraste

    • Nossos negócios
    • Passado, presente, futuro
    • A Fundação
    • Responsabilidade
  • Nosso portfólio

    Oferta comprovada para uma diferença comprovada

    • Raio-X & TC
      • Contrast agents

        • Iopamiron
        • Iomeron
      • Medical devices

        • Empower CTA
        • Empower CTA+
    • RM
      • Contrast agents

        • MultiHance
        • ProHance
      • Medical Devices

        • Empower MR
    • Ultrassom
      • Contrast agents

        • SonoVue
    • Medicina Nuclear
    • Cardiologia intervencionista
      • Contrast agents

        • Iomeron
      • Medical devices

        • ACIST CVi
    • Soluções digitais
    • Oncologia
    • Cardiologia
  • Woman looking into microscope
    Inovação

    Um profundo mergulho em nosso progresso de P&D

    • Futuro digital
    • P&D
    • Os sites Bracco
    • Patrimônio científico e patentes
  • knowledge
    Conhecimento

    O que sabemos e compartilhamos

    • E-learning
    • Parcerias em educação
    • Eventos
  • sustainability
    Sustentabilidade

    Nosso plano e objetivo para um mundo melhor

    • Nossos pilares de sustentabilidade
    • Governança
    • Nosso relatório de sustentabilidade
  • Nossas histórias
Article
Unlocking the AI Revolution Diana Bracco: “Artificial Intelligence will assist radiologists in making increasingly accurate and reliable diagnoses”
Symposium on the future of the Healthcare Industry and Diagnostic Imaging in the era of Artificial Intelligence
Article
Bracco Imaging announces global agreement with Subtle Medical Industry Leaders to Explore the Potential of AI in Contrast-Enhanced MRI.
BRACCO IMAGING S.p.A. ANNOUNCES GLOBAL AGREEMENT WITH SUBTLE MEDICAL, Inc.
Article
Vueway® (Gadopiclenol) Receives Positive CHMP Opinion The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approval of the macrocyclic, high-relaxivity Gadopiclenol in adults and pediatric patients older than 2 years of age.
Bracco Joined the United Nations Global Compact
Article
Bracco group celebrates twenty years of Bracco Spin During the conference “Sustainability, growth, employment: The Torviscosa model,” Bracco announced the plan to expand production capacity at its Torviscosa plant to meet the increasing demand for X-ray contrast agents, and will be making new hires
Diana Bracco riceve la cittadinanza onoraria di Torviscosa
Article
Diana Bracco: “we put people at the heart of sustainable development” During the conference "Sustainability, growth, employment: the Torviscosa model,” the Bracco Group presented its new Sustainability Report. The Report enumerates all the actions that Bracco, global leader in diagnostic imaging, has taken in favour of people, the planet and innovation.
Fulvio Renoldi Bracco Spin Torviscosa
Article
Bracco announces long term strategic partnership with ulrich medical The partnership will bring a Bracco branded state of the art MR injector to the United States under an exclusive private label arrangement.
EUSOMII interview
Article
The EC granted Marketing Authorisation for Vueway® (gadopiclenol) in the European Union Vueway®, a new macrocyclic gadolinium-based contrast agent for CE-MRI, received Marketing Authorisation in the European Union By European Commission.
Bracco Joined the United Nations Global Compact
Article
Samsung Medison and Bracco Imaging announce a new agreement Samsung Medison and Bracco Imaging endorsed a Memorandum of Understanding agreement to pioneer a new area for diagnostic ultrasound device and contrast agent at European Congress of Radiology 2024 held in Vienna, Austria on February 28th to March 3rd.
Samsung Medison (CEO, Mr. Yongkwan Kim) and Bracco Imaging (CEO, Dr. Fulvio Renoldi Bracco)
Article
JPR 2024 A Bracco do Brasil estará no maior Congresso de Radiologia da América Latina com seu portfólio completo de soluções em Diagnóstico por Imagem.
JPR 2024
Article
The Bracco Group announces the newly-created Bracco Japan The Bracco Group announces its direct presence in the Japanese market, where it has been doing business since 1990 through a successful joint venture with Eisai
Bracco Japan
  • Load More

O Grupo Bracco é um grupo internacional de empresas altamente especializadas.
Somos uma parte ativa do setor de saúde e líder global em diagnóstico por imagem.

  • Nós somos Bracco
  • Nosso portfólio
  • Inovação
  • Conhecimento
  • Sustentabilidade
  • Nossas histórias
  • Farmacovigilância
  • Data Protection

Siga-nos

Bracco Imaging do Brasil
Endereço Matriz:
AV. OL 3, 200 Duque de Caxias
Rio de Janeiro, CEP: 25085-375
Tel: 55 21 2772 1919
Escritório São Paulo
Rua Samuel Morse, 120 cj. 151/152
Cid. Monções, São Paulo-SP, CEP: 04576-060
Tel: 55 11 2181 2100
SAC: 0800 710
2100

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2025 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182